黑色素瘤生存在线预测工具的比较
该研究通过搜索引擎识别针对临床和病理特征的黑色素瘤生存在线预测列线图并进行比较,共识别出三种工具。美国癌症联合委员会工具将薄肿瘤不恰当地评为比中间肿瘤更高风险;路易斯维尔大学工具有六项不足;LifeMath.net工具在预测生存时恰当考虑了肿瘤厚度、溃疡、年龄、性别、部位和肿瘤亚型。作者认为LifeMath.net预测工具对临床医生为新诊断原发性皮肤黑色素瘤患者提供生存咨询最为可靠。
要点
- 共识别出三种黑色素瘤生存在线预测工具:美国癌症联合委员会工具、路易斯维尔大学工具和LifeMath.net工具。
- 美国癌症联合委员会工具将薄肿瘤不恰当地评为比中间肿瘤更高风险。
- LifeMath.net工具在预测生存时恰当考虑了肿瘤厚度、溃疡、年龄、性别、部位和肿瘤亚型。
核心结论
- 作者认为LifeMath.net预测工具对临床医生为新诊断原发性皮肤黑色素瘤患者提供生存咨询最为可靠。
研究设计与样本
- 研究使用搜索引擎识别可用的预测列线图,并对每种工具的临床和病理预测因子进行比较;共识别出三种工具。
主要发现
- 美国癌症联合委员会工具将薄肿瘤不恰当地评为比中间肿瘤更高风险。
- 路易斯维尔大学工具有六项不足:要求前哨淋巴结活检、无法输入薄黑色素瘤或70岁以上患者、年龄、溃疡和肿瘤厚度的风险比计算可靠性较低。
- LifeMath.net工具在预测生存时恰当考虑了肿瘤厚度、溃疡、年龄、性别、部位和肿瘤亚型。
临床怎么用
- 作者认为LifeMath.net预测工具对临床医生为新诊断原发性皮肤黑色素瘤患者提供生存咨询最为可靠。
局限性
- 作者无法获取用于编制各种预测工具的基础数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breslow thickness, patient age and ulceration are the three most valuable clinical and pathological predictors of melanoma survival. A readily available reliable online tool that accurately considers these and other predictors could be valuable for clinicians managing melanoma patients. OBJECTIVE: To compare online melanoma survival prediction tools that request user input on clinical and pathological features. METHODS: Search engines were used to identify available predictive nomograms. For each, clinical and pathological predictors were compared. RESULTS: Three tools were identified. The American Joint Committee on Cancer tool inappropriately rated thin tumours as higher risk than intermediate tumours. The University of Louisville tool was found to have six shortcomings: a requirement for sentinel node biopsy, unavailable input of thin melanoma or patients over 70 years of age and less reliable hazard ratio calculations for age, ulceration and tumour thickness. The LifeMath.net tool was found to appropriately consider tumour thickness, ulceration, age, sex, site and tumour subtype in predicting survival. LIMITATIONS: The authors did not have access to the base data used to compile various prediction tools. CONCLUSION: The LifeMath.net prediction tool is the most reliable for clinicians in counselling patients with newly diagnosed primary cutaneous melanoma regarding their survival prospects.
引用
- Dixon A, Steinman HK, Kyrgidis A, et al. Online prediction tools for melanoma survival: A comparison. J Eur Acad Dermatol Venereol. 2023. PMID: 37210649. doi:10.1111/jdv.19219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。